Insulin action and insulin resistance in human skeletal muscle
Open accessThe DOI matches its Crossref record; 168 of the 168 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A reduced sensitivity of skeletal muscle to insulin stimulation is one of the primary defects leading to the development of T2D [107].”
From Omega-3 Fatty Acids and Skeletal Muscle Health (2015) · cites this paper as [107]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,826 · cited 1×
“The serine/threonine kinase Akt is stimulated by receptor tyrosine kinases and is a downstream target of PI 3-kinase [32±34, 93], through activation of the phosphatidylinositol 3,4,5-trisphosphate-dependent protein kinase [94].”
BackgroundProtein kinase C and lipid signaling for sustained cellular responses
Nishizuka, Y. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.7.7737456 · Cited by 2,499 · cited 3×
“Insulin action and insulin resistance in human skeletal muscle J. R. Zierath1, A. Krook2, H.Wallberg-Henriksson2 1 Department of Clinical Physiology, Karolinska Hospital, Stockholm, Sweden 2 Department of Physiology and Pharmacology, Karolinska Institute, Stockholm Sweden Ó Springer-Verlag 2000 Corresponding author: J…”
BackgroundFranke, T. F., Yang, S.-I., Chan, T. O., Datta, K., Kazlauskas, A., Morrison, D. K., Kaplan, D. R., & Tsichlis, P. N. (1995) · Cell · doi:10.1016/0092-8674(95)90534-0 · Cited by 2,006
Disruption of IRS-2 causes type 2 diabetes in mice
Withers, D. J., Gutierrez, J. S., Towery, H., Burks, D. J., Ren, J.-M., Previs, S., Zhang, Y., Bernal, D., Pons, S., Shulman, G. I., et al. (1998) · Nature · doi:10.1038/36116 · Cited by 1,775 · cited 1×
“Evidence is emerging that the different IRS molecules have specialised roles in mediating metabolic and mitogenic effects of insulin [20, 21].”
BackgroundDeFronzo, R. A., Jacot, E., Jequier, E., Maeder, E., Wahren, J., & Felber, J. P. (1981) · Diabetes · doi:10.2337/diab.30.12.1000 · Cited by 1,770 · cited 3×
“From in vivo tracer studies, the defect in wholebody glucose uptake in Type II diabetic patients has been localised to the non-oxidative pathway for glucose metabolism [8, 13, 15, 16].”
BackgroundWhite, M. F., & Kahn, C. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42297-6 · Cited by 1,723
Kohn, A. D., Summers, S. A., Birnbaum, M. J., & Roth, R. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31372 · Cited by 1,284
Griffin, M. E., Marcucci, M. J., Cline, G. W., Bell, K., Barucci, N., Lee, D., Goodyear, L. J., Kraegen, E. W., White, M. F., & Shulman, G. I. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1270 · Cited by 1,267
Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene
Araki, E., Lipes, M. A., Patti, M.-E., Brüning, J. C., Haag III, B., Johnson, R. S., & Kahn, C. R. (1994) · Nature · doi:10.1038/372186a0 · Cited by 1,252 · cited 1×
“Evidence is emerging that the different IRS molecules have specialised roles in mediating metabolic and mitogenic effects of insulin [20, 21].”
BackgroundShulman, G. I., Rothman, D. L., Jue, T., Stein, P., DeFronzo, R. A., & Shulman, R. G. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001253220403 · Cited by 1,248 · cited 2×
“In the postprandial state, insulin-mediated glucose uptake and utilisation is greatly impaired in Type II diabetic patients [9, 12, 13] and in glucose tolerant first-degree relatives [12, 14].”
Background
Cited by
Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression
Lecker, S. H., Jagoe, R. T., Gilbert, A., Gomes, M., Baracos, V., Bailey, J., Price, S. R., Mitch, W. E., & Goldberg, A. L. (2004) · The FASEB Journal · doi:10.1096/fj.03-0610com · Cited by 1,539
“Insulin resistance is also a prominent feature of muscles in uremia, cancer cachexia, and fasting and should lead to enhanced proteolysis and reduced translation of new proteins (79).”
BackgroundAkt signalling in health and disease
Hers, I., Vincent, E. E., & Tavaré, J. M. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.05.004 · Cited by 1,239
Muscle‐derived interleukin‐6: mechanisms for activation and possible biological roles
FEBBRAIO, M. A., & PEDERSEN, B. K. (2002) · The FASEB Journal · doi:10.1096/fj.01-0876rev · Cited by 875
“Although the precise cause/s of peripheral insulin resistance associated with type 2 diabetes is/are not fully clear, recent research suggests that type 2 diabetics have defects in insulin signaling and GLUT4 trafficking (139).”
BackgroundRuegsegger, G. N., & Booth, F. W. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a029694 · Cited by 690
“Despite normal GLUT4 levels, insulin fails to induce GLUT4 translocation in T2D (Zierath et al. 2000).”
Oxidative stress and the etiology of insulin resistance and type 2 diabetes
Henriksen, E. J., Diamond-Stanic, M. K., & Marchionne, E. M. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.12.005 · Cited by 600
Invited Review: Effects of acute exercise and exercise training on insulin resistance
Henriksen, E. J. (2002) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01219.2001 · Cited by 535
“Insulin resistance in Type 2 diabetes, except for that observed in morbidly obese humans (29), is not generally associated with a decreased skeletal muscle level of GLUT-4 protein (117).”
BackgroundCurrent views on type 2 diabetes
Lin, Y., & Sun, Z. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0260 · Cited by 457
“Insulin receptor tyrosine phosphorylation appears to be normal or reduced in nonobese T2DM (Zierath et al. 2000).”
InfluentialExercise training‐induced improvements in insulin action
Hawley, J. A., & Lessard, S. J. (2008) · Acta Physiologica · doi:10.1111/j.1748-1716.2007.01783.x · Cited by 454
“…via an insulin-independent mechanism that bypasses the insulin signalling defects associated with these conditions (Wallberg-Henriksson & Holloszy 1984, DeFronzo et al. 1987, Ivy 1987, Cortez et al. 1991, Zierath et al. 2000, Christ-Roberts et al. 2003, Richter et al. 2004, O’Gorman et al. 2006).”
BackgroundBrooks, N., Layne, J. E., Gordon, P. L., Roubenoff, R., Nelson, M. E., & Castaneda-Sceppa, C. (2007) · International Journal of Medical Sciences · doi:10.7150/ijms.4.19 · Cited by 349
“Type 2 diabetes is a chronic disease characterized by hyperglycemia and disturbances of carbohydrate, fat and protein metabolism [1].”
BackgroundChemistry and Biochemistry of Type 2 Diabetes
Ross, S. A., Gulve, E. A., & Wang, M. (2004) · Chemical Reviews · doi:10.1021/cr0204653 · Cited by 323
Bouzakri, K., Roques, M., Gual, P., Espinosa, S., Guebre-Egziabher, F., Riou, J.-P., Laville, M., Le Marchand-Brustel, Y., Tanti, J.-F., & Vidal, H. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1319 · Cited by 305
“However, in vitro studies have evidenced cross-talk between the MAPK and the PI 3-kinase signaling pathways in several cell types, with a number of data indicating downregulatory effects of the MAPKs on PI 3-kinase activity (2,3).”
BackgroundPathophysiology of insulin resistance
Sesti, G. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.09.007 · Cited by 285
AS160 Regulates Insulin- and Contraction-stimulated Glucose Uptake in Mouse Skeletal Muscle
Kramer, H. F., Witczak, C. A., Taylor, E. B., Fujii, N., Hirshman, M. F., & Goodyear, L. J. (2006) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84060-7 · Cited by 285
Skeletal muscle insulin resistance: role of mitochondria and other ROS sources
Di Meo, S., Iossa, S., & Venditti, P. (2017) · Journal of Endocrinology · doi:10.1530/joe-16-0598 · Cited by 282
“It is also well established that skeletal muscle plays a central role in the whole body IR (Zierath et al. 2000).”
BackgroundAnalysis of paradoxical observations on the association between leptin and insulin resistance
Ceddia, R. B., Koistinen, H. A., Zierath, J. R., & Sweeney, G. (2002) · The FASEB Journal · doi:10.1096/fj.02-0158rev · Cited by 257
“In skeletal muscle, insulin-stimulated glucose uptake is mediated mainly by GLUT4 translocation from intracellular pools to the plasma membrane and PI3-kinase activation plays an important role in this process (81, 82).”
BackgroundSelf-citationOuwens, D. M., Boer, C., Fodor, M., de Galan, P., Heine, R. J., Maassen, J. A., & Diamant, M. (2005) · Diabetologia · doi:10.1007/s00125-005-1755-x · Cited by 256
“Although studies regarding insulin receptor activation in the skeletal muscle of type 2 diabetic subjects have yielded conflicting results [43], defects in insulin receptor activation were 1235”
BackgroundKoistinen, H. A., Galuska, D., Chibalin, A. V., Yang, J., Zierath, J. R., Holman, G. D., & Wallberg-Henriksson, H. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1066 · Cited by 232
“In skeletal muscle, glucose transport can be activated by distinct and separate pathways mediated by insulin, insulin-mimicking agents, and insulin-like growth factors, as well as by muscle contraction (exercise), cellular stress, and hypoxia (13).”
Self-citationInsulin signal transduction in human skeletal muscle: identifying the defects in Type II diabetes
Björnholm, M., & Zierath, J. R. (2005) · Biochemical Society Transactions · doi:10.1042/bst0330354 · Cited by 228
Self-citationO’Gorman, D. J., Karlsson, H. K. R., McQuaid, S., Yousif, O., Rahman, Y., Gasparro, D., Glund, S., Chibalin, A. V., Zierath, J. R., & Nolan, J. J. (2006) · Diabetologia · doi:10.1007/s00125-006-0457-3 · Cited by 226
“Thus, exercise has been considered to have positive effects on whole-body glucose homeostasis, and it has been suggested that these effects on metabolism bypass defects in insulin signalling in type 2 diabetes [6].”
BackgroundSelf-citationMashili, F. L., Austin, R. L., Deshmukh, A. S., Fritz, T., Caidahl, K., Bergdahl, K., Zierath, J. R., Chibalin, A. V., Moller, D. E., Kharitonenkov, A., et al. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1177 · Cited by 221
“T2D [43,51–53].”
Self-citationBouzakri, K., Zachrisson, A., Al-Khalili, L., Zhang, B. B., Koistinen, H. A., Krook, A., & Zierath, J. R. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.04.008 · Cited by 217
Self-citationInsulin-induced cortical actin remodeling promotes GLUT4 insertion at muscle cell membrane ruffles
Tong, P., Khayat, Z. A., Huang, C., Patel, N., Ueyama, A., & Klip, A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12348 · Cited by 211
“Importantly, there is ample evidence that GLUT4 externalization is defective in the pathophysiological state of insulin resistance underlying type 2 diabetes (5).”
BackgroundSmith, U. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802028 · Cited by 209
Omega-3 Fatty Acids and Skeletal Muscle Health
Jeromson, S., Gallagher, I., Galloway, S., & Hamilton, D. (2015) · Marine Drugs · doi:10.3390/md13116977 · Cited by 203
“EPA also reduced the amount of C:18-2 CoA beyond that of control and again this effect was more pronounced in T2D myotubes.”
BackgroundInfluentialEmerging Role of Nitric Oxide and Heat Shock Proteins in Insulin Resistance
Molina, M. N., Ferder, L., & Manucha, W. (2016) · Current Hypertension Reports · doi:10.1007/s11906-015-0615-4 · Cited by 199
Uusitupa, M., Lindi, V., Louheranta, A., Salopuro, T., Lindström, J., Tuomilehto, J., & for the Finnish Diabetes Prevention Study Group (2003) · Diabetes · doi:10.2337/diabetes.52.10.2532 · Cited by 196
Emerging Roles for MicroRNAs in Diabetic Microvascular Disease: Novel Targets for Therapy
Zhang, Y., Sun, X., Icli, B., & Feinberg, M. W. (2017) · Endocrine Reviews · doi:10.1210/er.2016-1122 · Cited by 183
“its effect on three main target tissues: fat, liver, and skeletalmuscle (66).”
BackgroundHuang, C., Thirone, A. C. P., Huang, X., & Klip, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412317200 · Cited by 180
Metformin as an Adjunct Therapy in Adolescents With Type 1 Diabetes and Insulin Resistance
Hamilton, J., Cummings, E., Zdravkovic, V., Finegood, D., & Daneman, D. (2003) · Diabetes Care · doi:10.2337/diacare.26.1.138 · Cited by 161
Lower Serum Creatinine Is a New Risk Factor of Type 2 Diabetes
Harita, N., Hayashi, T., Sato, K. K., Nakamura, Y., Yoneda, T., Endo, G., & Kambe, H. (2009) · Diabetes Care · doi:10.2337/dc08-1265 · Cited by 158
Hammarstedt, A., Jansson, P.-A., Wesslau, C., Yang, X., & Smith, U. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00014-7 · Cited by 156
Sending the Signal: Molecular Mechanisms Regulating Glucose Uptake
KROOK, A., WALLBERG-HENRIKSSON, H., & ZIERATH, J. R. (2004) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000132387.25853.3b · Cited by 150
“... translocation (31,38,49), one strategy to enhance glucose uptake in an insulin resistant skeletal muscle could potentially be through perturbation of an insulin-independent signaling cascade (Fig. 1). In skeletal muscle, glucose transport can be activated by at least two separate pathways, one stimulated by insuli…”
BackgroundSelf-citationThe role of free radicals, oxidative stress and antioxidant systems in diabetic vascular disease
Jakuš, V. (2000) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/bf03656352 · Cited by 181
Lambernd, S., Taube, A., Schober, A., Platzbecker, B., Görgens, S. W., Schlich, R., Jeruschke, K., Weiss, J., Eckardt, K., & Eckel, J. (2012) · Diabetologia · doi:10.1007/s00125-012-2454-z · Cited by 166
“Acute exercise increases glucose uptake in skeletal muscle by an insulin-independent mechanism that bypasses the insulin signalling defects associated with pathophysiological conditions [17].”
BackgroundHenriksen, E. J. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.04.002 · Cited by 136
“[4,7]).”
BackgroundRosiglitazone Improves Downstream Insulin Receptor Signaling in Type 2 Diabetic Patients
Miyazaki, Y., He, H., Mandarino, L. J., & DeFronzo, R. A. (2003) · Diabetes · doi:10.2337/diabetes.52.8.1943 · Cited by 135
Huang, C., Somwar, R., Patel, N., Niu, W., Török, D., & Klip, A. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2090 · Cited by 135
“The elevated glucose and insulin levels in turn exacerbate insulin resistance, contributing significantly to the pathogenesis of the disease (2).”
Muscle Wasting and Changes in Muscle Protein Metabolism in Chronic Obstructive Pulmonary Disease
Jagoe, R. T., & Engelen, M. P. K. J. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00004608 · Cited by 134
Krämer, D. K., Al-Khalili, L., Perrini, S., Skogsberg, J., Wretenberg, P., Kannisto, K., Wallberg-Henriksson, H., Ehrenborg, E., Zierath, J. R., & Krook, A. (2005) · Diabetes · doi:10.2337/diabetes.54.4.1157 · Cited by 132
“Type 2 diabetes is a clinical disorder of glucose and lipid metabolism that is partly caused by impaired glucose uptake into adipose tissue and skeletal muscle (1).”
BackgroundSelf-citationModulation of metabolic control by angiotensin converting enzyme (ACE) inhibition
Henriksen, E. J., & Jacob, S. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10294 · Cited by 132
“Insulin stimulation of skeletal muscle glucose transport results from the activation of a series of intracellular proteins (reviewed recently by Shepherd and Kahn, 1999; Zierath et al., 2000).”
BackgroundSkeletal Muscle Insulin Resistance in Endocrine Disease
Peppa, M., Koliaki, C., Nikolopoulos, P., & Raptis, S. A. (2010) · Journal of Biomedicine and Biotechnology · doi:10.1155/2010/527850 · Cited by 128
“However, whether these defects are actually a primary cause of IR or rather a secondary effect to an altered metabolic milieu remains still unresolved [11].”
BackgroundThe adipocyte–myocyte axis in insulin resistance
Sell, H., Dietze‐Schroeder, D., & Eckel, J. (2006) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2006.10.010 · Cited by 141
Glucose Homeostasis During Short-term and Prolonged Exposure to High Altitudes
Woolcott, O. O., Ader, M., & Bergman, R. N. (2015) · Endocrine Reviews · doi:10.1210/er.2014-1063 · Cited by 133
Bouzakri, K., Plomgaard, P., Berney, T., Donath, M. Y., Pedersen, B. K., & Halban, P. A. (2011) · Diabetes · doi:10.2337/db10-1178 · Cited by 122
“Skeletal muscle plays a major role in whole-body substrate homeostasis in the postprandial state, and impaired action on this tissue contributes to the pathological condition of insulin resistance (14).”
BackgroundImprovement of insulin sensitivity by antagonism of the renin-angiotensin system
Henriksen, E. J. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00147.2007 · Cited by 123
Lee, J., Kim, D., & Kim, C. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0258-3 · Cited by 123
“Second, given that carbohydrate, fat, and protein metabolism are interrupted in diabetes [60] and declined vascular supply and peripheral neuropathy may be the reasons why muscle mass loss is related to impaired glycemic control [51], T2D may have negative effects on the alterations of muscle mass.”
BackgroundOxidant stress-induced loss of IRS-1 and IRS-2 proteins in rat skeletal muscle: Role of p38 MAPK
Archuleta, T. L., Lemieux, A. M., Saengsirisuwan, V., Teachey, M. K., Lindborg, K. A., Kim, J. S., & Henriksen, E. J. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.08.014 · Cited by 123
Dokken, B. B., Saengsirisuwan, V., Kim, J. S., Teachey, M. K., & Henriksen, E. J. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00578.2007 · Cited by 123
“Specific defects in the ability of insulin to normally activate insulin signaling factors, including the insulin receptor (IR), IR substrate-1 (IRS-1), phosphatidylinositol 3-kinse (PI 3-kinase), and Akt are known to contribute to this insulin resistance in skeletal muscle (9, 11, 35).”
BackgroundTalior, I., Tennenbaum, T., Kuroki, T., & Eldar-Finkelman, H. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00378.2004 · Cited by 120
“activating PKCs, and it has been shown by numerous studies that, in cells chronically exposed to high glucose or in hypergluycemic animals, PKC is activated (20, 27, 29, 48).”
BackgroundBulhak, A. A., Jung, C., Östenson, C.-G., Lundberg, J. O., Sjöquist, P.-O., & Pernow, J. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00394.2008 · Cited by 116
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Harrison, S. A., & Neuschwander‐Tetri, B. A. (2004) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.06.008 · Cited by 127
Treating insulin resistance in type 2 diabetes with metformin and thiazolidinediones
Bailey, C. J. (2005) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00497.x · Cited by 121
Esteves, J. V. D. C., Enguita, F. J., & Machado, U. F. (2017) · Journal of Diabetes Research · doi:10.1155/2017/7267910 · Cited by 121
Oliveira, L. M. A., Lages, A., Gomes, R. A., Neves, H., Família, C., Coelho, A. V., & Quintas, A. (2011) · BMC Biochemistry · doi:10.1186/1471-2091-12-41 · Cited by 117
“External administration of insulin is critical in Diabetes type I, where autoimmune response causes a progressive and permanent destruction of the insulin-producing cells in the pancreas due to an interplay of environmental and genetic factors [1-3].”
BackgroundHenriksen, E. J., Kinnick, T. R., Teachey, M. K., O'Keefe, M. P., Ring, D., Johnson, K. W., & Harrison, S. D. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00346.2002 · Cited by 108
Influence of Acute and Chronic Exercise on Glucose Uptake
Röhling, M., Herder, C., Stemper, T., & Müssig, K. (2016) · Journal of Diabetes Research · doi:10.1155/2016/2868652 · Cited by 131
“In type 2 diabetes patients, despite a normal amount of GLUT4 transporters [112], insulin fails, in general, to induce adequate insulin signaling as assessed by IRS-1 tyrosine phosphorylation, Akt/PKB activity, and translocation of GLUT4 to the cell membrane [113–116].”
BackgroundMolecular aspects of diabetes mellitus: Resistin, microRNA, and exosome
Saeedi Borujeni, M. J., Esfandiary, E., Taheripak, G., Codoñer‐Franch, P., Alonso‐Iglesias, E., & Mirzaei, H. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26271 · Cited by 106
“Among the insulin targeted organs, skeletal muscle is responsible for more than 80% of glucose disposal induced by insulin.(53,54) Insulin receptor is a heterotetrameric protein composed of two extracellular alpha subunits and two trans-membrane beta subunits with kinase activities at their intracellular domain.”
BackgroundDokken, B. B., Sloniger, J. A., & Henriksen, E. J. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00547.2004 · Cited by 105
“Moreover, the enhancement of IRS-1 associated with p85 elicited by the GSK3 inhibition is likely causally related to the increase in insulin-stimulated glucose transport activity, since the activation of PI 3-kinase by tyrosine-phosphorylated IRS-1 is necessary for insulin-stimulated translocation of GLUT4 protein to…”
BackgroundHuang, S., Yu, R.-T., Gong, J., Feng, Y., Dai, Y.-L., Hu, F., Hu, Y., Tao, Y.-D., & Leng, Y. (2011) · Diabetologia · doi:10.1007/s00125-011-2366-3 · Cited by 109
“Several factors, such as muscle contraction (exercise), hypoxia and cellular stress have been demonstrated to increase glucose transport independently of insulin in skeletal muscle, effects to which the activation of AMP-activated protein kinase (AMPK) has been suggested to contribute [6–8].”
BackgroundChang, W., Zhang, M., Li, J., Meng, Z., Wei, S., Du, H., Chen, L., & Hatch, G. M. (2013) · Metabolism · doi:10.1016/j.metabol.2013.02.007 · Cited by 105
“The elevated glucose and insulin levels in turn exacerbate insulin resistance, which results in dysfunction of myocardium and contributes to the pathogenesis of diabetic cardiomyopathy [25].”
BackgroundOterdoom, L. H., van Ree, R. M., de Vries, A. P. J., Gansevoort, R. T., Schouten, J. P., van Son, W. J., van der Heide, J. J. H., Navis, G., de Jong, P. E., Gans, R. O. B., et al. (2008) · Transplantation · doi:10.1097/tp.0b013e3181788aea · Cited by 108
“In obese subjects and in patients with type 2 diabetes, there is resistance to insulin-stimulated uptake of glucose (9, 10, 13).”
BackgroundPrevalence and Mechanisms of Skeletal Muscle Atrophy in Metabolic Conditions
Jun, L., Robinson, M., Geetha, T., Broderick, T. L., & Babu, J. R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032973 · Cited by 115
“Thus, as with T1DM patients, glucose uptake via GLUT4 and metabolism of glucose by muscle are reduced by insulin resistance [81].”
BackgroundFoster, L. J., Li, D., Randhawa, V. K., & Klip, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102964200 · Cited by 97
Diabetes in Zucker Diabetic Fatty Rat
Shiota, M., & Printz, R. L. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-068-7_8 · Cited by 104
Pinto-Junior, D. C., Silva, K. S., Michalani, M. L., Yonamine, C. Y., Esteves, J. V., Fabre, N. T., Thieme, K., Catanozi, S., Okamoto, M. M., Seraphim, P. M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-26482-6 · Cited by 91
Liu, H.-Y., Cao, S. Y., Hong, T., Han, J., Liu, Z., & Cao, W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.016675 · Cited by 91
The role of the renin-angiotensin system in the development of insulin resistance in skeletal muscle
Henriksen, E. J., & Prasannarong, M. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.04.011 · Cited by 96
“…it is clear that that most insulin-resistant states develop as a consequence of the defective expression and functionality of critical upstream insulin signaling proteins, such as the insulin receptor and IRS (reviewed in Zierath et al., 2000; Henriksen, 2002, 2010; Henriksen et al., 2011).”
BackgroundOf rodents and men: Species-specific glucose regulation and type 2 diabetes research
Chandrasekera, P. C. (2014) · ALTEX · doi:10.14573/1309231 · Cited by 89
Henriksen, E. J., Teachey, M. K., Taylor, Z. C., Jacob, S., Ptock, A., Krämer, K., & Hasselwander, O. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00013.2003 · Cited by 89
Storgaard, H., Song, X. M., Jensen, C. B., Madsbad, S., Björnholm, M., Vaag, A., & Zierath, J. R. (2001) · Diabetes · doi:10.2337/diabetes.50.12.2770 · Cited by 82
Self-citationReduced Leg Blood Flow during Submaximal Exercise in Type 2 Diabetes
Lalande, S., Gusso, S., Hofman, P. L., & Baldi, J. C. (2008) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e318161aa99 · Cited by 95
“derived free radicals, and the formation of advanced glycation end products (5,6,13,30).”
BackgroundResistance Training and Older Adults with Type 2 Diabetes Mellitus: Strength of the Evidence
Hovanec, N., Sawant, A., Overend, T. J., Petrella, R. J., & Vandervoort, A. A. (2012) · Journal of Aging Research · doi:10.1155/2012/284635 · Cited by 79
“It has been suggested that people with T2DM have a defective insulindependent pathway, which is responsible for activating glucose transporters of the muscles to help move the glucose from the blood into the cells [65].”
BackgroundInfluentialAl-Khalili, L., Forsgren, M., Kannisto, K., Zierath, J. R., Lönnqvist, F., & Krook, A. (2005) · Diabetologia · doi:10.1007/s00125-005-1741-3 · Cited by 78
“Defects in whole-body glucose uptake are closely linked to impaired insulinstimulated glucose transport activity [6].”
BackgroundSelf-citationOxidant stress and skeletal muscle glucose transport: Roles of insulin signaling and p38 MAPK
Kim, J. S., Saengsirisuwan, V., Sloniger, J. A., Teachey, M. K., & Henriksen, E. J. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.05.031 · Cited by 78
Stentz, F. B., & Kitabchi, A. E. (2007) · Genomics Proteomics & Bioinformatics · doi:10.1016/s1672-0229(08)60009-1 · Cited by 81
Matos, M. A. D., Vieira, D. V., Pinhal, K. C., Lopes, J. F., Dias-Peixoto, M. F., Pauli, J. R., Castro Magalhães, F. D., Little, J. P., Rocha-Vieira, E., & Amorim, F. T. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01451 · Cited by 75
Urocortin 2 modulates glucose utilization and insulin sensitivity in skeletal muscle
Chen, A., Brar, B., Choi, C. S., Rousso, D., Vaughan, J., Kuperman, Y., Kim, S. N., Donaldson, C., Smith, S. M., Jamieson, P., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607337103 · Cited by 75
Berberine modulates insulin signaling transduction in insulin-resistant cells
Liu, L., Cheung, S. C. K., Lan, L., Ho, S. K. S., Xu, H., Chan, J. C. N., & Tong, P. C. Y. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.12.027 · Cited by 80
Skeletal muscle and insulin sensitivity: pathophysiological alterations
Ryder, J. (2001) · Frontiers in bioscience · doi:10.2741/ryder · Cited by 73
“Likewise, in vivo insulin infusion in type II diabetic subjects is accompanied by normal levels of Akt phosphorylation (56) and kinase activity (30) within skeletal muscle, despite reduced whole-body glucose utilization.”
BackgroundFerretti, R., Moura, E. G., dos Santos, V. C., Caldeira, E. J., Conte, M., Matsumura, C. Y., Pertille, A., & Mosqueira, M. (2018) · PLOS ONE · doi:10.1371/journal.pone.0199728 · Cited by 71
“the insulin receptor substrate 1 (IRS1), phosphoinositide 3-kinase (PI3K), and a 62 serine-threonine protein kinase (AKT) [5].”
BackgroundZIERATH, J. R., & WALLBERG‐HENRIKSSON, H. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04270.x · Cited by 71
Self-citationExercise protects against glucose intolerance in individuals with a small body size at birth
Eriksson, J. G., Ylihärsilä, H., Forsén, T., Osmond, C., & Barker, D. J. P. (2004) · Preventive Medicine · doi:10.1016/j.ypmed.2004.01.035 · Cited by 80
Yonamine, C., Pinheiro-Machado, E., Michalani, M., Alves-Wagner, A., Esteves, J., Freitas, H., & Machado, U. (2017) · Molecules · doi:10.3390/molecules22071180 · Cited by 71
“Skeletal muscle accounts for approximately 75% of whole-body insulin-stimulated glucose disposal [34,35], which explains the central role of muscle in the insulin resistance induced impairment of glycemic homeostasis, especially in the postprandial period.”
BackgroundWhite, D., & Collinson, A. (2013) · Advances in Nutrition · doi:10.3945/an.113.003681 · Cited by 83
“Postprandial concentrations of amino acids, particularly branched chain, interfere with insulin signaling in animals (53) and in humans (54) by inhibiting the early stages of postinsulin receptor activity, preventing phosphorylation of insulin receptor substrates and subsequent protein kinase C and other kinase subuni…”
BackgroundAdvances in the Understanding and Treatment of Nonalcoholic Fatty Liver Disease
Harrison, S. A., & Bisceglie, A. M. D. (2003) · Drugs · doi:10.2165/00003495-200363220-00001 · Cited by 79
Effect of Antihypertensive Agents on the Development of Type 2 Diabetes Mellitus
Stump, C. S., Hamilton, M. T., & Sowers, J. R. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.6.796 · Cited by 73
Weber, M. B., Oza‐Frank, R. B., Staimez, L. R., Ali, M. K., & Narayan, K. M. V. (2012) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071811-150630 · Cited by 76
Catechins enhance skeletal muscle performance
Li, P., Liu, A., Xiong, W., Lin, H., Xiao, W., Huang, J., Zhang, S., & Liu, Z. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1549534 · Cited by 70
“One is the phosphatidylinositol 3-kinase (PI3K) pathway stimulated by insulin and the other is the AMPK pathway mediated by muscle contraction (Goodyear et al. 1996; Widegren et al. 1998; Zierath et al. 2000).”
BackgroundMeyer, M., Levin, K., Grimmsmann, T., Beck‐Nielsen, H., & Klein, H. H. (2002) · Diabetologia · doi:10.1007/s00125-002-0830-9 · Cited by 78
“Binding of tyrosine-phosphorylated insulin receptor substrates to the 85 kDa regulatory subunit of the lipid kinase phosphatidylinositol-3′(PI3′)-kinase then results in an activation of this enzyme, which is necessary for the insulin-mediated stimulation of glucose uptake and glycogen synthase [13].”
BackgroundAltered Response of Skeletal Muscle to IL-6 in Type 2 Diabetic Patients
Jiang, L. Q., Duque-Guimaraes, D. E., Machado, U. F., Zierath, J. R., & Krook, A. (2013) · Diabetes · doi:10.2337/db11-1790 · Cited by 65
“Indeed, insulin-stimulated Akt phosphorylation in skeletal muscle is unaltered in type 2 diabetic patients studied in vivo, despite profound impairments in glucose disposal (35,36).”
BackgroundSelf-citationLooijaard, S. M. L. M., Hekkert, M. L. T. L., Wüst, R. C. I., Otten, R. H. J., Meskers, C. G. M., & Maier, A. B. (2020) · Acta Physiologica · doi:10.1111/apha.13516 · Cited by 74
Hartell, N. A., Archer, H. E., & Bailey, C. J. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.11.022 · Cited by 67
Increased adipose tissue expression of Grb14 in several models of insulin resistance
Cariou, B., Capitaine, N., Le Marcis, V., Vega, N., Béréziat, V., Kergoat, M., Laville, M., Girard, J., Vidal, H., & Burnol, A.-F. (2004) · The FASEB Journal · doi:10.1096/fj.03-0824fje · Cited by 64
“For instance, IRS-1 and GLUT4 expressions are decreased in adipocytes from type 2 diabetic subjects, whereas there is no difference in skeletal muscle (17-19).”
BackgroundLiao, W., Xu, N., Zhang, H., Liao, W., Wang, Y., Wang, S., Zhang, S., Jiang, Y., Xie, W., & Zhang, Y. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.699 · Cited by 74
Separation of Insulin Signaling into Distinct GLUT4 Translocation and Activation Steps
Funaki, M., Randhawa, P. K., & Janmey, P. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.17.7567-7577.2004 · Cited by 64
“In skeletal muscles of type 2 diabetes patients, insulin-induced GLUT4 translocation is markedly reduced, although the impairment in upstream signaling events, such as phosphorylation of IRS-1 and Akt, is modest ( 68 ).”
BackgroundImprovement of obesity-linked skeletal muscle insulin resistance by strength and endurance training
Meo, S. D., Iossa, S., & Venditti, P. (2017) · Journal of Endocrinology · doi:10.1530/joe-17-0186 · Cited by 77
“It is also well established that skeletal muscle plays an important role in whole body IR (Zierath et al. 2000) so that many researchers focused on this tissue.”
BackgroundInfluentialAngiotensin converting enzyme inhibitors and modulation of skeletal muscle insulin resistance
Henriksen, E. J., & Jacob, S. (2003) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2003.00265.x · Cited by 63
Esteves, J. V. D. C., Yonamine, C. Y., Júnior, D. A. C. P., Gerlinger‐Romero, F., Enguita, F. J., & Machado, U. F. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00536 · Cited by 65
“The skeletal muscle represents about 40% of body mass; because of that, it is responsible for ∼80% of insulin-stimulated glucose uptake in healthy subjects (3), and is considered the major site of peripheral insulin resistance (4).”
BackgroundHow Does Physical Activity Modulate Hormone Responses?
Mennitti, C., Farina, G., Imperatore, A., Fonzo, G. D., Gentile, A., Civita, E. L., Carbone, G., Simone, R. R. D., Iorio, M. R. D., Tinto, N., et al. (2024) · Biomolecules · doi:10.3390/biom14111418 · Cited by 91
Anand, S., Muthusamy, V., Sujatha, S., Sangeetha, K. N., Raja, R., Selvaraju, S., Devi, N., & Lakshmi, B. S. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.06.004 · Cited by 69
“Pathogenesis of NIDDM involves a combination of genetic and environmental factors, which cause insulin resistance in target tissues [22].”
Background
Metadata
- Authors
- Zierath, J. R., Krook, A., & Wallberg-Henriksson, H.
- Affiliations
- Karolinska University Hospital (SE)
- Karolinska Institutet (SE)
- Venue
- Diabetologia
- Published
- 2000-07-03
- Volume
- 43
- Issue
- 7
- Pages
- 821-835
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2069929383
- Cited by
- 367
- References
- 159
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 14 · 2023: 13 · 2022: 12 · 2021: 14 · 2020: 11 · 2019: 10 · 2018: 17 · 2017: 22 · 2016: 4 · 2015: 11 · 2014: 14 · 2013: 17 · 2012: 16
- FWCI
- 5.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Keywords
- insulin action, insulin resistance, skeletal muscle, insulin signaling, glucose metabolism
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Glucose, Humans, Hyperglycemia, Insulin, Insulin Resistance, Signal Transduction, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.